Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Shares Shorted: Short Interest Down 52.2% in October

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) saw a significant decrease in short interest in October. As of October 30th, there was short interest totaling 14,956 shares, a decrease of 52.2% from the October 15th total of 31,307 shares. Based on an average daily volume of 27,864 shares, the days-to-cover ratio is presently 0.5 days. Currently, 0.3% of the shares of the company are sold short.

Shuttle Pharmaceuticals Stock Performance

Shares of NASDAQ:SHPH traded down $0.23 during trading on Friday, reaching $4.53. The company had a trading volume of 10,276 shares, compared to its average volume of 28,411. The firm’s fifty day moving average is $4.49 and its 200 day moving average is $6.41. The firm has a market capitalization of $21.56 million, a PE ratio of -0.24 and a beta of -0.04. Shuttle Pharmaceuticals has a twelve month low of $2.58 and a twelve month high of $44.40.

Analyst Ratings Changes

Separately, Weiss Ratings cut shares of Shuttle Pharmaceuticals from a “sell (e+)” rating to a “sell (e)” rating in a research note on Tuesday. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, Shuttle Pharmaceuticals currently has a consensus rating of “Sell”.

Shuttle Pharmaceuticals Company Profile

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) is a clinical-stage biopharmaceutical company focused on developing therapies designed to improve the effectiveness of radiation treatment for cancer. The company’s research is centered on radiosensitizers, drugs intended to make cancer cells more vulnerable to radiation while potentially limiting damage to surrounding healthy tissue. Shuttle’s lead candidate is ropidoxuridine, also known as iododeoxyuridine or IUdR, an investigational radiosensitizing agent being evaluated for use with radiotherapy.